Literature DB >> 19084883

The evolution of drug-resistant malaria.

Christopher V Plowe1.   

Abstract

Molecular epidemiological investigations have uncovered the patterns of emergence and global spread of Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine. Malaria parasites highly resistant to chloroquine and pyrimethamine spread from Asian origins to Africa, at great cost to human health and life. If artemisinin-resistant falciparum malaria follows the same pattern, renewed efforts to eliminate and eradicate malaria will be gravely threatened. This paper, adapted from a talk given in honour of Professor Malcolm Molyneux in Liverpool in September 2008, reviews the rise and fall of clinically important forms of drug-resistant falciparum malaria and considers how lessons learned from studying the evolution of drug-resistant malaria can be applied to efforts to prevent and deter resistance.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19084883      PMCID： PMC2723787          DOI： 10.1016/j.trstmh.2008.11.002

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


  14 in total

1.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

Authors:  James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

2.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

3.  Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Authors:  D S Peterson; D Walliker; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis.

Authors:  O K Doumbo; K Kayentao; A Djimde; J F Cortese; Y Diourte; A Konaré; J G Kublin; C V Plowe
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

5.  Return of chloroquine antimalarial efficacy in Malawi.

Authors:  Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

6.  P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates.

Authors:  C V Plowe; J G Kublin; O K Doumbo
Journal:  Drug Resist Updat       Date:  1998       Impact factor: 18.500

Review 7.  Monitoring and deterring drug-resistant malaria in the era of combination therapy.

Authors:  Miriam K Laufer; Abdoulaye A Djimdé; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

Authors:  Alisa P Alker; Pharath Lim; Rithy Sem; Naman K Shah; Poravuth Yi; Denis Mey Bouth; Reiko Tsuyuoka; Jason D Maguire; Thierry Fandeur; Frederic Ariey; Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

9.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.

Authors:  James G Kublin; Joseph F Cortese; Eric Mbindo Njunju; Rabia A G Mukadam; Jack J Wirima; Peter N Kazembe; Abdoulaye A Djimdé; Bourema Kouriba; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2003-05-21       Impact factor: 5.226

10.  World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Authors:  Christopher V Plowe; Cally Roper; John W Barnwell; Christian T Happi; Hema H Joshi; Wilfred Mbacham; Steven R Meshnick; Kefas Mugittu; Inbarani Naidoo; Ric N Price; Robert W Shafer; Carol H Sibley; Colin J Sutherland; Peter A Zimmerman; Philip J Rosenthal
Journal:  Malar J       Date:  2007-09-06       Impact factor: 2.979
View more
  57 in total

1.  Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.

Authors:  Sungano Mharakurwa; Taida Kumwenda; Mtawa A P Mkulama; Mulenga Musapa; Sandra Chishimba; Clive J Shiff; David J Sullivan; Philip E Thuma; Kun Liu; Peter Agre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).

Authors:  Paul M Riegelhaupt; I J Frame; Myles H Akabas
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

3.  Malaria: A race against resistance.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2013-11-14       Impact factor: 49.962

4.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

5.  Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches.

Authors:  Eric H Ekland; Jessica Schneider; David A Fidock
Journal:  FASEB J       Date:  2011-07-11       Impact factor: 5.191

6.  The Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication.

Authors:  Christopher V Plowe
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 7.  Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.

Authors:  Carol Hopkins Sibley; Ric N Price
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-20       Impact factor: 4.077

8.  Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties.

Authors:  Farhana Mosaddeque; Shusaku Mizukami; Mohamed Gomaa Kamel; Awet Alem Teklemichael; Truong Van Dat; Satoshi Mizuta; Dinh Van Toan; Ali Mahmoud Ahmed; Nguyen Lam Vuong; Mohamed Tamer Elhady; Hoang Thi Nam Giang; Tran Ngoc Dang; Michiko Fukuda; Lam K Huynh; Yoshimasa Tanaka; Timothy J Egan; Osamu Kaneko; Nguyen Tien Huy; Kenji Hirayama
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

9.  Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii.

Authors:  Sumanta Dey; Somnath Mazumder; Asim Azhar Siddiqui; M Shameel Iqbal; Chinmoy Banerjee; Souvik Sarkar; Rudranil De; Manish Goyal; Samik Bindu; Uday Bandyopadhyay
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

10.  Reduced digestive vacuolar accumulation of chloroquine is not linked to resistance to chloroquine toxicity.

Authors:  Mynthia Cabrera; Michelle F Paguio; Changan Xie; Paul D Roepe
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.